הכנסה לפני ניכוי ריבית, מסים ופחת: Anteris Technologies Global (AVR)

Geopolitical tensions are hindering material supplies and the distribution of Anteris Technologies Global (AVR) systems in several countries. The operating profit history in monetary terms reflects current trends, where the 0.00 mark indicates the yield level. Growth is driven by the unique DurAVR bioprosthesis with significant pricing power, although success depends on the outcome of clinical trials and capital expenditure control.

The development of innovative heart valves by Anteris Technologies Global requires high capital expenditure, making the monitoring of cash flow from operating activities critical. This metric measures the net financial return from commercial operations before taxes and interest, allowing investors to assess the real scalability of the business and the risk of overpaying for the asset via the EBIT trend on GURU.Markets.